share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director High Katherine A

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director High Katherine A

CRISPR Therapeutics | 4：持股變動聲明-董事 High Katherine A
美股sec公告 ·  06/01 04:21
牛牛AI助理已提取核心訊息
Katherine A. High, associated with CRISPR Therapeutics (CRSP.US), was involved in a transaction on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding CRISPR Therapeutics stock.
Katherine A. High, associated with CRISPR Therapeutics (CRSP.US), was involved in a transaction on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding CRISPR Therapeutics stock.
與CRISPR Therapeutics（CRSP.US）相關的凱瑟琳·海於2024年5月30日參與了一筆交易。公告中未披露交易的具體細節，包括行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。建議投資者等待進一步的信息，以充分了解此事件對他們有關CRISPR Therapeutics股票的投資決策的影響。
與CRISPR Therapeutics（CRSP.US）相關的凱瑟琳·海於2024年5月30日參與了一筆交易。公告中未披露交易的具體細節，包括行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。建議投資者等待進一步的信息，以充分了解此事件對他們有關CRISPR Therapeutics股票的投資決策的影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。